Coronary Inflammation by Computed Tomography Pericoronary Fat Attenuation and Increased Cytokines in Young Male Anabolic Androgenic Steroid Users

Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ARQUIVOS BRASILEIROS CARDIOLOGIA
Autores
Citação
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, v.120, n.11, article ID e20220822, 8p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Anabolic androgenic steroid (AAS) abuse has been associated with coronary artery disease (CAD). Pericoronary fat attenuation (pFA) is a marker of coronary inflammation, which is key in the atherosclerotic process.Objective: To evaluate pFA and inflammatory profile in AAS users.Methods: Twenty strength-trained AAS users (AASU), 20 AAS nonusers (AASNU), and 10 sedentary controls (SC) were evaluated. Coronary inflammation was evaluated by mean pericoronary fat attenuation (mPFA) in the right coronary artery (RCA), left anterior descending coronary artery (LAD), and left circumflex (LCx). Interleukin (IL)-1 (IL-1), IL-6, IL-10, and TNF-alpha were evaluated by optical density (OD) in a spectrophotometer with a 450 nm filter. P<0.05 indicated statistical significance.Results: AASU had higher mPFA in the RCA (-65.87 [70.51-60.70] vs.-78.07 [83.66-72.87] vs.-78.46 [85.41-71.99] Hounsfield Units (HU), respectively, p<0.001) and mPFA in the LAD (-71.47 [76.40-66.61] vs.-79.32 [84.37-74.59] vs.-82.52 [88.44-75.81] HU, respectively, p=0.006) compared with AASNU and SC. mPFA in the LCx was not different between AASU, AASNU, and SC (-72.41 [77.17-70.37] vs.-80.13 [86.22-72.23] vs.-78.29 [80.63-72.29] HU, respectively, p=0.163). AASU compared with AASNU and SC, had higher IL-1, (0.975 [0.847-1.250] vs. 0.437 [0.311-0.565] vs. 0.530 [0.402-0.780] OD, respectively, p=0.002), IL-6 (1.195 [0.947-1.405] vs. 0.427 [0.377-0.577] vs. 0.605 [0.332-0.950] OD, p=0.005) and IL-10 (1.145 [0.920-1.292] vs. 0.477 [0.382-0.591] vs. 0.340 [0.316-0.560] OD, p<0.001). TNF-alpha was not different between the AASU, AASNU, and SC groups (0.520 [0.250-0.610] vs. 0.377 [0.261-0.548] vs. 0.350 [0.182-430]), respectively.Conclusion: Compared with ASSNU and controls, AASU have higher mPFA and higher systemic inflammatory cytokines profile suggesting that AAS may induce coronary atherosclerosis through coronary and systemic inflammation.
Palavras-chave
Coronary Artery Disease, Pericoronary Fat Attenuation, Anabolic Androgenic Steroids
URI
https://observatorio.fm.usp.br/handle/OPI/57877
Referências
  1. Abbara S, 2016, J CARDIOVASC COMPUT, V10, P435, DOI 10.1016/j.jcct.2016.10.002
  2. Abdelrahman KM, 2020, J AM COLL CARDIOL, V76, P1226, DOI 10.1016/j.jacc.2020.06.076
  3. Angell P, 2012, SPORTS MED, V42, P119, DOI 10.2165/11598060-000000000-00000
  4. Antoniades C, 2019, J CARDIOVASC COMPUT, V13, P288, DOI 10.1016/j.jcct.2019.03.006
  5. Antonopoulos AS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2658
  6. Bacchiega BC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005038
  7. Baggish AL, 2017, CIRCULATION, V135, P1991, DOI 10.1161/CIRCULATIONAHA.116.026945
  8. Dai X, 2020, INT J CARDIOVAS IMAG, V36, P723, DOI 10.1007/s10554-019-01758-8
  9. de Souza FR, 2022, INT J SPORTS MED, V43, P183, DOI 10.1055/a-1518-7953
  10. de Souza FR, 2019, ATHEROSCLEROSIS, V283, P100, DOI 10.1016/j.atherosclerosis.2019.02.006
  11. de Souza FR, 2019, SCAND J MED SCI SPOR, V29, P422, DOI 10.1111/sms.13332
  12. dos Santos MR, 2013, INT J SPORTS MED, V34, P931, DOI 10.1055/s-0032-1331741
  13. dos Santos MR, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e226
  14. Gaibazzi N, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013235
  15. Hoefer IE, 2015, EUR HEART J, V36, P2635, DOI 10.1093/eurheartj/ehv236
  16. Lopes RD, 2010, ARQ BRAS CARDIOL, V94, P313, DOI 10.1590/S0066-782X2010000300006
  17. Alves MJNN, 2010, MED SCI SPORT EXER, V42, P865, DOI 10.1249/MSS.0b013e3181c07b74
  18. Nomura CH, 2020, EUR HEART J-CARD IMG, V21, P599, DOI 10.1093/ehjci/jeaa023
  19. Oikonomou EK, 2018, LANCET, V392, P929, DOI 10.1016/S0140-6736(18)31114-0
  20. Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401
  21. Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
  22. Sampaio BFC, 2014, CLIN MICROBIOL INFEC, V20, pO72, DOI 10.1111/1469-0691.12295
  23. Santora Lawrence J, 2006, Prev Cardiol, V9, P198, DOI 10.1111/j.1559-4564.2006.05210.x
  24. Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05
  25. Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677
  26. Yu MM, 2020, EUR RADIOL, V30, P673, DOI 10.1007/s00330-019-06400-8

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - IMT
Carregar mais